Two Sigma, D.E. Shaw join pushback against SEC proposal to relax quarterly reporting

Wall Street firms including Two Sigma, D.E. Shaw, Citadel and Fidelity are pushing back against an SEC proposal that could let U.S.-listed companies opt out of quarterly reporting in favor of semi-annual disclosures. Opponents say the change would reduce transparency and increase volatility, while supporters argue it would lower reporting burdens. The SEC is expected to formally seek public comment in coming weeks, making this a potentially sector-wide regulatory issue.

Analysis

This is not primarily a disclosure debate; it is a fight over who controls the information edge. If semi-annual reporting becomes optional, dispersion rises immediately because fundamental investors lose one of the few standardized data points that keeps small caps and low-liquidity names priceable with confidence. That tends to widen bid-ask spreads, lower turnover, and push capital toward a smaller set of megacaps where analyst coverage and alternative data can partially replace missing filings.

The second-order winner is not management teams broadly, but companies with stable cash conversion and less cyclical businesses that can tolerate a longer silence window. The losers are exactly the names that already depend on frequent communication to support valuation multiples: lower-quality small caps, levered cyclicals, and firms with aggressive accounting where quarterly scrutiny forces discipline. If this gets traction, expect a valuation gap between transparent reporters and opt-outs, similar to a governance discount that can persist for multiple quarters once investors re-rate the information risk.

For the listed managers, the more important impact is on factor behavior than on headline sentiment. Reduced disclosure frequency should mechanically increase volatility around earnings windows, but more importantly it should raise the cost of carry for long/short books that rely on timely revisions, making fast-fundamental and event-driven strategies relatively disadvantaged while index and quality-factor products gain. That is supportive for JPM’s franchise in capital markets and advisory if volatility and primary issuance rise, but negative for asset gatherers like BLK and TROW if retail and institutional clients interpret the rule change as a deterioration in market fairness and choose to de-risk small-cap allocations.

The contrarian point is that the proposal may be more bark than bite: even if the SEC advances it, large issuers with existing investor bases will still report quarterly to avoid a discount, so the effective regime could remain bifurcated rather than fully relaxed. The real tradeable outcome is a policy-path volatility spike over the next 1-3 months, not an immediate structural regime shift. That argues for positioning around headline risk and relative liquidity effects rather than making a blanket market call.

Key Decisions for Investors

• Long JPM / short BLK as a 1-3 month relative-value trade: JPM should benefit if disclosure reform increases market volatility, issuance activity, and trading volumes, while BLK is more exposed to a broad client pushback narrative and any de-risking from public-market governance concerns.
• Reduce exposure to small-cap beta via IWM vs. maintain or add to QQQ: if reporting frequency becomes optional, the most likely near-term effect is a higher information premium in less-covered names, which should underperform in a lower-transparency regime.
• Buy 2-4 month straddles on a small-cap liquidity-sensitive basket or XBI/IWM proxy into the SEC comment window: the setup is for policy-driven volatility, and options monetize the uncertainty better than directionally betting the final rule.
• Pair trade long quality/megacap balance sheets against levered lower-quality publics: use SPLV or QQQ against IWM/SMID names; the market should reward firms least dependent on frequent disclosure to maintain funding access.
• Tactically underweight TROW on the next policy headline, but cover quickly if the SEC signals a narrow exemption rather than broad opt-out: TROW’s downside is sentiment and fee-pressure driven, yet the move should reverse if the proposal is watered down.